The STAT3-miRNA-92-Wnt signaling pathway regulates spheroid formation and malignant progression in ovarian cancer

Min Wei Chen, Shu Ting Yang, Ming Hsien Chien, Kuo Tai Hua, Chin Jui Wu, S. M. Hsiao, Hao Lin, Michael Hsiao, Jen Liang Su, Lin Hung Wei

研究成果: 雜誌貢獻文章

38 引文 (Scopus)

摘要

Ovarian cancer spheroids constitute a metastatic niche for transcoelomic spread that also engenders drug resistance. Spheroid-forming cells express active STAT3 signaling and display stem cell-like properties that may contribute to ovarian tumor progression. In this study, we show that STAT3 is hyperactivated in ovarian cancer spheroids and that STAT3 disruption in this setting is sufficient to relieve chemoresistance. In an NSG murine model of human ovarian cancer, STAT3 signaling regulated spheroid formation and self-renewal properties, whereas STAT3 attenuation reduced tumorigenicity. Mechanistic investigations revealed that Wnt signaling was required for STAT3-mediated spheroid formation. Notably, the Wnt antagonist DKK1 was the most strikingly upregulated gene in response to STAT3 attenuation in ovarian cancer cells. STAT3 signaling maintained stemness and interconnected Wnt/β-catenin signaling via the miR-92a/DKK1-regulatory pathways. Targeting STAT3 in combination with paclitaxel synergistically reduced peritoneal seeding and prolonged survival in a murine model of intraperitoneal ovarian cancer. Overall, our findings define a STAT3-miR-92a-DKK1 pathway in the generation of cancer stem-like cells in ovarian tumors, with potential therapeutic applications in blocking their progression.

原文英語
頁(從 - 到)1955-1967
頁數13
期刊Cancer Research
77
發行號8
DOIs
出版狀態已發佈 - 四月 15 2017

指紋

Wnt Signaling Pathway
MicroRNAs
Ovarian Neoplasms
Catenins
Neoplastic Stem Cells
Paclitaxel
Drug Resistance
Neoplasms
Stem Cells
Survival
Genes

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

引用此文

The STAT3-miRNA-92-Wnt signaling pathway regulates spheroid formation and malignant progression in ovarian cancer. / Chen, Min Wei; Yang, Shu Ting; Chien, Ming Hsien; Hua, Kuo Tai; Wu, Chin Jui; Hsiao, S. M.; Lin, Hao; Hsiao, Michael; Su, Jen Liang; Wei, Lin Hung.

於: Cancer Research, 卷 77, 編號 8, 15.04.2017, p. 1955-1967.

研究成果: 雜誌貢獻文章

Chen, MW, Yang, ST, Chien, MH, Hua, KT, Wu, CJ, Hsiao, SM, Lin, H, Hsiao, M, Su, JL & Wei, LH 2017, 'The STAT3-miRNA-92-Wnt signaling pathway regulates spheroid formation and malignant progression in ovarian cancer', Cancer Research, 卷 77, 編號 8, 頁 1955-1967. https://doi.org/10.1158/0008-5472.CAN-16-1115
Chen, Min Wei ; Yang, Shu Ting ; Chien, Ming Hsien ; Hua, Kuo Tai ; Wu, Chin Jui ; Hsiao, S. M. ; Lin, Hao ; Hsiao, Michael ; Su, Jen Liang ; Wei, Lin Hung. / The STAT3-miRNA-92-Wnt signaling pathway regulates spheroid formation and malignant progression in ovarian cancer. 於: Cancer Research. 2017 ; 卷 77, 編號 8. 頁 1955-1967.
@article{c99d4b94899e405c812a5063674dae28,
title = "The STAT3-miRNA-92-Wnt signaling pathway regulates spheroid formation and malignant progression in ovarian cancer",
abstract = "Ovarian cancer spheroids constitute a metastatic niche for transcoelomic spread that also engenders drug resistance. Spheroid-forming cells express active STAT3 signaling and display stem cell-like properties that may contribute to ovarian tumor progression. In this study, we show that STAT3 is hyperactivated in ovarian cancer spheroids and that STAT3 disruption in this setting is sufficient to relieve chemoresistance. In an NSG murine model of human ovarian cancer, STAT3 signaling regulated spheroid formation and self-renewal properties, whereas STAT3 attenuation reduced tumorigenicity. Mechanistic investigations revealed that Wnt signaling was required for STAT3-mediated spheroid formation. Notably, the Wnt antagonist DKK1 was the most strikingly upregulated gene in response to STAT3 attenuation in ovarian cancer cells. STAT3 signaling maintained stemness and interconnected Wnt/β-catenin signaling via the miR-92a/DKK1-regulatory pathways. Targeting STAT3 in combination with paclitaxel synergistically reduced peritoneal seeding and prolonged survival in a murine model of intraperitoneal ovarian cancer. Overall, our findings define a STAT3-miR-92a-DKK1 pathway in the generation of cancer stem-like cells in ovarian tumors, with potential therapeutic applications in blocking their progression.",
author = "Chen, {Min Wei} and Yang, {Shu Ting} and Chien, {Ming Hsien} and Hua, {Kuo Tai} and Wu, {Chin Jui} and Hsiao, {S. M.} and Hao Lin and Michael Hsiao and Su, {Jen Liang} and Wei, {Lin Hung}",
year = "2017",
month = "4",
day = "15",
doi = "10.1158/0008-5472.CAN-16-1115",
language = "English",
volume = "77",
pages = "1955--1967",
journal = "Cancer Research",
issn = "0008-5472",
publisher = "American Association for Cancer Research Inc.",
number = "8",

}

TY - JOUR

T1 - The STAT3-miRNA-92-Wnt signaling pathway regulates spheroid formation and malignant progression in ovarian cancer

AU - Chen, Min Wei

AU - Yang, Shu Ting

AU - Chien, Ming Hsien

AU - Hua, Kuo Tai

AU - Wu, Chin Jui

AU - Hsiao, S. M.

AU - Lin, Hao

AU - Hsiao, Michael

AU - Su, Jen Liang

AU - Wei, Lin Hung

PY - 2017/4/15

Y1 - 2017/4/15

N2 - Ovarian cancer spheroids constitute a metastatic niche for transcoelomic spread that also engenders drug resistance. Spheroid-forming cells express active STAT3 signaling and display stem cell-like properties that may contribute to ovarian tumor progression. In this study, we show that STAT3 is hyperactivated in ovarian cancer spheroids and that STAT3 disruption in this setting is sufficient to relieve chemoresistance. In an NSG murine model of human ovarian cancer, STAT3 signaling regulated spheroid formation and self-renewal properties, whereas STAT3 attenuation reduced tumorigenicity. Mechanistic investigations revealed that Wnt signaling was required for STAT3-mediated spheroid formation. Notably, the Wnt antagonist DKK1 was the most strikingly upregulated gene in response to STAT3 attenuation in ovarian cancer cells. STAT3 signaling maintained stemness and interconnected Wnt/β-catenin signaling via the miR-92a/DKK1-regulatory pathways. Targeting STAT3 in combination with paclitaxel synergistically reduced peritoneal seeding and prolonged survival in a murine model of intraperitoneal ovarian cancer. Overall, our findings define a STAT3-miR-92a-DKK1 pathway in the generation of cancer stem-like cells in ovarian tumors, with potential therapeutic applications in blocking their progression.

AB - Ovarian cancer spheroids constitute a metastatic niche for transcoelomic spread that also engenders drug resistance. Spheroid-forming cells express active STAT3 signaling and display stem cell-like properties that may contribute to ovarian tumor progression. In this study, we show that STAT3 is hyperactivated in ovarian cancer spheroids and that STAT3 disruption in this setting is sufficient to relieve chemoresistance. In an NSG murine model of human ovarian cancer, STAT3 signaling regulated spheroid formation and self-renewal properties, whereas STAT3 attenuation reduced tumorigenicity. Mechanistic investigations revealed that Wnt signaling was required for STAT3-mediated spheroid formation. Notably, the Wnt antagonist DKK1 was the most strikingly upregulated gene in response to STAT3 attenuation in ovarian cancer cells. STAT3 signaling maintained stemness and interconnected Wnt/β-catenin signaling via the miR-92a/DKK1-regulatory pathways. Targeting STAT3 in combination with paclitaxel synergistically reduced peritoneal seeding and prolonged survival in a murine model of intraperitoneal ovarian cancer. Overall, our findings define a STAT3-miR-92a-DKK1 pathway in the generation of cancer stem-like cells in ovarian tumors, with potential therapeutic applications in blocking their progression.

UR - http://www.scopus.com/inward/record.url?scp=85018797659&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85018797659&partnerID=8YFLogxK

U2 - 10.1158/0008-5472.CAN-16-1115

DO - 10.1158/0008-5472.CAN-16-1115

M3 - Article

C2 - 28209618

AN - SCOPUS:85018797659

VL - 77

SP - 1955

EP - 1967

JO - Cancer Research

JF - Cancer Research

SN - 0008-5472

IS - 8

ER -